Walid A. Mourad

1.1k total citations
42 papers, 742 citations indexed

About

Walid A. Mourad is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Walid A. Mourad has authored 42 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Walid A. Mourad's work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (9 papers) and Cancer Genomics and Diagnostics (7 papers). Walid A. Mourad is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (9 papers) and Cancer Genomics and Diagnostics (7 papers). Walid A. Mourad collaborates with scholars based in Saudi Arabia, United States and Canada. Walid A. Mourad's co-authors include Walid Hassan, Alaa Mokhtar, Nabil K. Bissada, Kamal A. Hanash, Said Kattan, Raouf Seyam, Yasser Khafaga, Hassan M. Alzahrani, Shouki Bazarbashi and Muhammad Aslam and has published in prestigious journals such as Cancer, The Journal of Urology and The American Journal of Surgical Pathology.

In The Last Decade

Walid A. Mourad

39 papers receiving 711 citations

Peers

Walid A. Mourad
Naomi Kawano Japan
Perkins Mukunyadzi United States
K. H. Fu China
André Pinto United States
Vincenzo Pitini Italy
Chueh‐Chuan Yen Taiwan
Pascal Godmer France
Netta Mäkinen Finland
Bryan Lin United States
Konrad Ptaszyński Poland
Naomi Kawano Japan
Walid A. Mourad
Citations per year, relative to Walid A. Mourad Walid A. Mourad (= 1×) peers Naomi Kawano

Countries citing papers authored by Walid A. Mourad

Since Specialization
Citations

This map shows the geographic impact of Walid A. Mourad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid A. Mourad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid A. Mourad more than expected).

Fields of papers citing papers by Walid A. Mourad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid A. Mourad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid A. Mourad. The network helps show where Walid A. Mourad may publish in the future.

Co-authorship network of co-authors of Walid A. Mourad

This figure shows the co-authorship network connecting the top 25 collaborators of Walid A. Mourad. A scholar is included among the top collaborators of Walid A. Mourad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid A. Mourad. Walid A. Mourad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mourad, Walid A., Abdelghani Tbakhi, Yasser Khafaga, et al.. (2008). Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyterich large B-cell lymphoma and lymphocytepredominant Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy. 1(1). 22–27. 4 indexed citations
2.
Seyam, Raouf, Nabil K. Bissada, Said Kattan, et al.. (2008). Changing Trends in Presentation, Diagnosis and Management of Renal Angiomyolipoma: Comparison of Sporadic and Tuberous Sclerosis Complex-associated Forms. Urology. 72(5). 1077–1082. 122 indexed citations
3.
Weshi, Amr El, Saad Akhtar, Walid A. Mourad, et al.. (2007). T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature. Leukemia & lymphoma. 48(9). 1764–1773. 36 indexed citations
4.
Seyam, Raouf, Nabil K. Bissada, Alaa Mokhtar, et al.. (2006). Outcome of Penile Cancer in Circumcised Men. The Journal of Urology. 175(2). 557–561. 12 indexed citations
5.
6.
Mourad, Walid A., et al.. (2000). Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagnostic Cytopathology. 22(4). 223–226. 27 indexed citations
7.
Mustafa, Mahmoud M., Arif Jamshed, Yasser Khafaga, et al.. (1999). Adjuvant Chemotherapy With Vincristine, Doxorubicin, and Cyclophosphamide in the Treatment of Postenucleation High Risk Retinoblastoma. Journal of Pediatric Hematology/Oncology. 21(5). 364–369. 19 indexed citations
8.
Mourad, Walid A., et al.. (1998). Primary T-Cell Lymphoma of the Urinary Bladder. The American Journal of Surgical Pathology. 22(3). 373–377. 24 indexed citations
9.
Yakimets, Walter W., et al.. (1997). Fine-needle aspiration cytology of sarcomatoid carcinoma of the breast: A cytologically overlooked neoplasm. Diagnostic Cytopathology. 16(3). 242–246. 13 indexed citations
10.
Mourad, Walid A., et al.. (1997). Predictors of Invasion in Ductal Carcinoma in Situ of the Breast: The Value of a Scoring System. Annals of Saudi Medicine. 17(4). 427–431. 2 indexed citations
11.
Jamshed, Arif, et al.. (1997). Primary Hodgkin's disease of the mandible. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 83(6). 680–684. 18 indexed citations
12.
Mourad, Walid A., et al.. (1996). Fine-needle aspiration cytology of bronchocentric granulomatosis: A potential diagnostic pitfall. Diagnostic Cytopathology. 14(3). 263–267. 6 indexed citations
13.
Mourad, Walid A., et al.. (1994). Correlation of two AgNOR counts with Ki‐67 labeling index: A study in fine‐needle aspirates of lymphoproliferative disorders and breast carcinoma. Diagnostic Cytopathology. 10(2). 113–119. 12 indexed citations
14.
Mourad, Walid A., William Pugh, Yang O. Huh, & Michael J. Keating. (1994). Cell Kinetic Analysis of lnterleukin-2 Receptor-tested Chronic Lymphocytic Leukemia Using the AgNOR Silver Stain. American Journal of Clinical Pathology. 101(3). 300–304. 7 indexed citations
15.
Mourad, Walid A., Nour Sneige, Ruth L. Katz, Nancy P. Caraway, & Tina V. Fanning. (1994). Fine‐needle aspiration cytology of recurrent and metastatic mixed mesodermal tumors. Diagnostic Cytopathology. 11(4). 328–332. 3 indexed citations
16.
17.
18.
Mourad, Walid A., Bruce Mackay, Nelson G. Ordóǹez, Jae Y. Ro, & David A. Swanson. (1993). Clear Cell Melanoma of the Bladder. Ultrastructural Pathology. 17(3). 463–468. 21 indexed citations
19.
20.
Mourad, Walid A., et al.. (1992). Two AgNOR counts in fine‐needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry. Diagnostic Cytopathology. 8(2). 128–134. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naomi Kawano Breakdown of academic impact, for papers by Perkins Mukunyadzi Breakdown of academic impact, for papers by K. H. Fu Breakdown of academic impact, for papers by André Pinto Breakdown of academic impact, for papers by Vincenzo Pitini Breakdown of academic impact, for papers by Chueh‐Chuan Yen Breakdown of academic impact, for papers by Pascal Godmer Breakdown of academic impact, for papers by Netta Mäkinen Breakdown of academic impact, for papers by Bryan Lin Breakdown of academic impact, for papers by Konrad Ptaszyński
Rankless by CCL
2026